Clinical trial
Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
This phase II trial is studying how well dasatinib works as first-line therapy in treating patients with gastrointestinal stromal tumors.
| Category | Value |
|---|---|
| Study start date | 2007-12-05 |